Covered recipient · General Payments record
ANDREW MICHAEL ROTH
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2023–2024
$489.60
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $476.79 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $254.14 | 5 |
| Laborie Medical Technologies Corp. | $49.21 | 2 |
| UCB, Inc. | $46.15 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $40.89 | 1 |
| DEXCOM, INC. | $20.94 | 1 |
| Amgen Inc. | $19.05 | 1 |
| Exeltis, USA Inc. | $16.71 | 1 |
| IBSA Pharma Inc. | $16.55 | 1 |
| Seqirus USA Inc | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.05 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117369687 | CMS |
| Dexcom, Inc. | $20.94 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279677 | CMS |
| Exeltis, USA Inc. | $16.71 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150003406 | CMS |
| GENZYME CORPORATION | $33.35 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139993755 | CMS |
| GENZYME CORPORATION | $99.48 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139993791 | CMS |
| GENZYME CORPORATION | $49.59 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139993811 | CMS |
| GENZYME CORPORATION | $33.14 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139993821 | CMS |
| GENZYME CORPORATION | $38.58 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139993839 | CMS |
| IBSA Pharma Inc. | $16.55 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142978394 | CMS |
| Laborie Medical Technologies Corp. | $24.53 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154320028 | CMS |
| Laborie Medical Technologies Corp. | $24.68 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154320030 | CMS |
| Seqirus USA Inc | $13.15 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125636757 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $40.89 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152125385 | CMS |
| UCB, Inc. | $46.15 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143504486 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.